论文部分内容阅读
目的探究甲状腺全切术治疗甲状腺癌的安全性及临床有效性。方法采集我院2014年4月至2016年7月甲状腺癌患者144例资料随机分组。甲组用甲状腺次全切手术治疗;乙组则实施甲状腺全切术治疗。比较两组患者甲状腺癌治疗效果;手术时间、出血和出院时间;二次手术率、复发率、甲状腺功能低下出现率。结果乙组患者甲状腺癌治疗效果和甲组相似,P>0.05;乙组手术时间、出血和出院时间和甲组相似,P>0.05;乙组二次手术率、复发率显著低于甲组,甲状腺功能低下出现率比甲组高,P<0.05。结论甲状腺全切术治疗甲状腺癌的安全性及临床有效性高,可降低复发率和二次手术率,但容易出现甲状腺功能低下。
Objective To investigate the safety and clinical efficacy of total thyroidectomy for thyroid cancer. Methods A total of 144 patients with thyroid cancer from April 2014 to July 2016 in our hospital were randomly divided into two groups. Group A with subtotal thyroidectomy; Group B is the implementation of total thyroidectomy. Thyroid cancer treatment was compared between two groups; operation time, bleeding and discharge time; secondary surgery rate, recurrence rate, the incidence of hypothyroidism. Results The treatment effect of thyroid cancer in group B was similar to that of group A (P> 0.05); the operation time, bleeding time and discharge time in group B were similar to those in group A (P> 0.05); The second operation rate and recurrence rate in group B were significantly lower than that in group A The incidence of hypothyroidism was higher than that of group A (P <0.05). Conclusions Thyroidectomy for the treatment of thyroid cancer has high safety and clinical efficacy, which can reduce the recurrence rate and the rate of secondary surgery, but it is prone to have hypothyroidism.